How to Apply to Miltenyi Biotec

9 min read Last updated April 20, 2026

Key Takeaways

  • Miltenyi Biotec is a privately held, family-owned German biotech invented around Stefan Miltenyi's MACS technology, with no IPO pressure and a multi-decade horizon.
  • CliniMACS Prodigy is the market-defining instrument for academic CAR-T and cell therapy manufacturing, which gives Miltenyi durable strategic leverage even as broader bioprocessing markets normalize.
  • Headquarters in Bergisch Gladbach is rural Nordrhein-Westfalen near Cologne, not a major metro; commute and relocation realities should be weighed honestly.
  • The careers portal is custom (not Workday or SuccessFactors), expects a single combined PDF, and parses conservatively; format simply and use exact keywords.
  • Hiring is slow, deliberate, and PhD-heavy in research roles; expect research seminars, multiple rounds, and three to eight weeks to offer.
  • German HQ roles operate within a Betriebsrat-influenced, IG BCE-adjacent labor framework with strong worker protections, six weeks of vacation, and tariff-banded pay.
  • Auburn CA, Cambridge MA, and Rome NY are the major US sites; compensation is competitive within bio-tools but not at Bay Area software levels.
  • Honest red flags to weigh: rural HQ location, slow decisions, conservative culture, and a bioprocessing market still recovering from post-COVID destocking.

About Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG is a privately held German biotechnology company headquartered in Bergisch Gladbach, Nordrhein-Westfalen, in the Cologne area. Founded in 1989 by Dr. Stefan Miltenyi, a PhD physicist who invented MACS (Magnetic Activated Cell Sorting) technology, the company has grown from a single inventive insight into one of the most strategically important suppliers in the global cell therapy ecosystem. Stefan Miltenyi remains President and stays actively engaged in the business, and the family plus management retain ownership; there is no public listing, no private equity sponsor, and no near-term IPO pressure shaping decisions. That ownership structure matters when you evaluate Miltenyi as an employer: priorities are set on a multi-decade horizon, R&D investment does not pulse with quarterly earnings, and senior leadership turnover is unusually low for a company of this size. Miltenyi employs roughly 5,000 people across more than 30 countries, with subsidiaries spanning North America, Europe, Asia-Pacific, and India. Beyond the Bergisch Gladbach headquarters, major sites include Teterow in northeastern Germany (large-scale manufacturing and reagent production), Munich, Auburn, California (Cell Therapy and Bioprocess solutions for the Americas), Cambridge, Massachusetts, Rome, New York (radiosynthesis), Paris, Singapore, Beijing, Tokyo, Seoul, and Mumbai. The product portfolio is broad and unusually vertically integrated for a company of this size: the foundational MACS platform of magnetic columns and reagents; flow cytometry instruments such as the MACSQuant Analyzer and the MACSQuant Tyto cell sorter; clinical-grade cell processing systems led by the CliniMACS Prodigy, which has become the workhorse closed-system instrument for academic CAR-T and other cell therapy manufacturing worldwide; single-cell technology and reagents; the MACSima imaging system for high-plex single-cell imaging; and Miltenyi Biomedicine, a clinical-stage therapeutics arm developing CD19-directed CAR-T and NK cell therapy programs. The 2024-2025 environment is mixed but net-favorable for Miltenyi. The bioprocessing tools market continues to normalize after the COVID-era destocking that pressured peers like Sartorius and Cytiva, so the broader research-reagent business is recovering rather than booming. At the same time, academic and commercial CAR-T expansion is real and ongoing, and CliniMACS Prodigy is the market-defining instrument in academic cell therapy manufacturing. Miltenyi Biomedicine has been the subject of recurring spin-out rumors as the therapeutics pipeline matures. Be honest with yourself about what this means: Miltenyi is a deep-technical, scientist-led, German-engineered company with a long-term horizon, not a fast-moving consumer software employer, and the pace and decision style reflect that.

Application Process

  1. 1
    Search openings at jobs

    Search openings at jobs.miltenyibiotec.com and filter by location, function, and contract type; the German custom careers portal is the canonical source and many roles never appear on LinkedIn.

  2. 2
    Decide upfront which site you are targeting (Bergisch Gladbach HQ, Teterow manuf

    Decide upfront which site you are targeting (Bergisch Gladbach HQ, Teterow manufacturing, Auburn CA, Cambridge MA, Rome NY, Paris, Singapore, Beijing, Tokyo, Seoul, or Mumbai) because language, work permits, and reporting lines differ substantially between regions.

  3. 3
    Create a candidate profile in the Miltenyi portal and attach a single PDF that b

    Create a candidate profile in the Miltenyi portal and attach a single PDF that bundles cover letter, CV, transcripts, and reference letters; German hiring norms expect this combined application package, especially for HQ roles.

  4. 4
    Tailor your CV to the exact requisition, using the German chronological format w

    Tailor your CV to the exact requisition, using the German chronological format with photo and detailed education for DE roles, and a US-style achievements-driven CV for Auburn, Cambridge, and Rome NY postings.

  5. 5
    Reference the specific Miltenyi product line in your cover letter (MACS, MACSQua

    Reference the specific Miltenyi product line in your cover letter (MACS, MACSQuant, CliniMACS Prodigy, MACSima, Miltenyi Biomedicine) so the recruiter sees you understand what the team actually builds.

  6. 6
    Expect first contact from a regional Talent Acquisition partner via email within

    Expect first contact from a regional Talent Acquisition partner via email within one to three weeks for active requisitions; pipeline applications can sit longer because Miltenyi hires slowly and deliberately.

  7. 7
    Prepare for an initial recruiter screen of about thirty minutes covering motivat

    Prepare for an initial recruiter screen of about thirty minutes covering motivation, technical background, language proficiency, salary expectation in local currency, and notice period.

  8. 8
    Plan on two to four technical or scientific interviews with hiring manager, peer

    Plan on two to four technical or scientific interviews with hiring manager, peers, and a senior leader; PhD scientist roles often add a one-hour seminar where you present your prior research to a panel.

  9. 9
    For German roles, be ready to discuss tariff classification, vacation entitlemen

    For German roles, be ready to discuss tariff classification, vacation entitlement, Betriebsrat (works council) interactions, and probation period (Probezeit), which is typically six months.

  10. 10
    Final offers are issued by HR with a signed contract sent for countersignature;

    Final offers are issued by HR with a signed contract sent for countersignature; expect background and reference checks, and for clinical or manufacturing roles, occupational health screening before the start date.


Resume Tips for Miltenyi Biotec

recommended

Lead with the specific Miltenyi product family or therapeutic area you are targe

Lead with the specific Miltenyi product family or therapeutic area you are targeting (MACS reagents, CliniMACS Prodigy, MACSima imaging, Miltenyi Biomedicine clinical programs) so the recruiter immediately sees fit.

recommended

Quantify scientific output with publications, citations, patents, and clinical t

Quantify scientific output with publications, citations, patents, and clinical trial milestones; PhD-heavy hiring panels weight peer-reviewed evidence heavily and treat unverified claims skeptically.

recommended

For bioprocess and manufacturing engineers, name the regulatory frameworks you h

For bioprocess and manufacturing engineers, name the regulatory frameworks you have worked under (ISO 13485, EU MDR, FDA 21 CFR Part 820, GMP Annex 1) and the cleanroom classes (ISO 5/7/8) you have operated in.

recommended

Spell out flow cytometry, cell separation, single-cell sequencing, or imaging cy

Spell out flow cytometry, cell separation, single-cell sequencing, or imaging cytometry experience by platform and panel size; competing platforms (BD, Beckman Coulter, Cytek, Sony, 10x Genomics) are recognized and welcomed.

recommended

If you are applying to a German site, use the European CV format with a professi

If you are applying to a German site, use the European CV format with a professional photo, date of birth, nationality, and full education history including grades; omitting these signals unfamiliarity with the market.

recommended

State language proficiency precisely using CEFR levels (German A2/B1/B2/C1, Engl

State language proficiency precisely using CEFR levels (German A2/B1/B2/C1, English C1/C2) rather than vague phrases; many DE roles require working German even when English is the team language.

recommended

Highlight any direct CliniMACS Prodigy, CliniMACS Plus, or MACSQuant hands-on ex

Highlight any direct CliniMACS Prodigy, CliniMACS Plus, or MACSQuant hands-on experience with hours of use and protocols developed; this is rare and immediately differentiates a candidate.

recommended

For Miltenyi Biomedicine roles, list GCP training, IND or CTA submission experie

For Miltenyi Biomedicine roles, list GCP training, IND or CTA submission experience, and clinical trial phases you have supported (Phase 1 through pivotal) along with indication areas.

recommended

Show longevity in prior roles where you can; Miltenyi values long-tenure scienti

Show longevity in prior roles where you can; Miltenyi values long-tenure scientists and engineers and reads short-stint patterns as a yellow flag in a family-owned culture.

recommended

Save and submit as a single PDF named LastName_FirstName_Position

Save and submit as a single PDF named LastName_FirstName_Position.pdf, keep CV plus cover letter to four to six pages combined, and avoid overdesigned templates that confuse the custom ATS parser.



Interview Culture

Miltenyi interview culture is distinctly German, scientifically rigorous, and unrushed.

Expect direct, content-focused questions rather than American-style behavioral theater; interviewers care more about whether you actually understand the science and engineering than whether you can deliver a polished STAR story. Loops typically run two to four rounds: a recruiter screen, a hiring manager technical conversation, peer interviews with the team you would join, and for senior roles a conversation with a department head or general manager. PhD scientist roles almost always include a research seminar where you present your prior work for forty-five to sixty minutes to a panel that may include scientists who have never met you, followed by aggressive but collegial Q&A; this is standard German academic-industry practice and not a hostile gesture. Decisions take time. The combination of Betriebsrat (works council) involvement on German hires, family-ownership patience, and a culture that prefers to get the right person rather than fill the seat fast means three to eight weeks from final interview to offer is common. Compensation conversations are matter-of-fact: in Germany, expect a tariff-aligned salary banded by experience and education with thirteenth-month or vacation pay, six weeks of vacation, and strong pension contributions; in the US, expect competitive but not Bay Area-tech base, a meaningful annual bonus, and good benefits. Negotiation works but should be evidence-based, not theatrical. Across all sites the cultural through-line is the same: deep technical respect, low political drama, a long-term horizon, and the assumption that you are joining for a real career rather than a two-year stint.

What Miltenyi Biotec Looks For

  • Demonstrated technical depth in a relevant domain (cell biology, immunology, flow cytometry, bioprocess engineering, single-cell genomics, imaging, regulatory affairs) backed by publications, patents, or shipped products.
  • Direct hands-on experience with Miltenyi platforms (MACS, CliniMACS Prodigy, MACSQuant, MACSima) or with named competitors (BD, Beckman Coulter, Cytek, 10x Genomics, Lonza Cocoon, Cytiva Sefia) that translates cleanly.
  • Comfort with German engineering culture: precise documentation, change control, traceability, and a willingness to do things slowly and correctly rather than fast and approximately.
  • Language fit for the site (working German for HQ and Teterow, working English universally, plus regional languages for Asia-Pacific and Europe sites).
  • Regulatory literacy in the relevant framework (ISO 13485, EU MDR, IVDR, FDA 21 CFR Part 820, GMP Annex 1, GCP, GDP) for any role touching clinical, manufacturing, or quality.
  • Evidence of long-tenure career patterns and genuine interest in cell therapy or research tools as a domain rather than as a stepping stone.
  • For commercial roles, demonstrated success selling complex scientific instruments or reagents into academic, pharma, or biotech accounts with consultative, multi-stakeholder cycles.
  • Cross-cultural competence and willingness to work with international colleagues across European, North American, and Asian time zones.
  • Intellectual honesty in interviews about what you have and have not done; embellishment is detected quickly by PhD-heavy panels and is treated as disqualifying.
  • Genuine curiosity about Miltenyi specifically (the MACS invention story, CliniMACS Prodigy in CAR-T manufacturing, the Biomedicine pipeline) rather than generic biotech interest.

Frequently Asked Questions

Is Miltenyi Biotec publicly traded?
No. Miltenyi Biotec B.V. & Co. KG is privately held by the Miltenyi family and management. There is no stock listing on Frankfurt, NYSE, or NASDAQ, and there has been no announced IPO. That structure shapes hiring, compensation (no public-market equity), and strategic patience in ways that distinguish it from publicly traded competitors like BD, Danaher, Bio-Rad, Cytek, or 10x Genomics.
Where is Miltenyi headquartered and what are the major sites?
Headquarters are in Bergisch Gladbach, Nordrhein-Westfalen, in the greater Cologne area of Germany. Major additional sites include Teterow in northeastern Germany (manufacturing), Munich, Auburn in California, Cambridge in Massachusetts, Rome in New York (radiosynthesis), Paris, Singapore, Beijing, Tokyo, Seoul, and Mumbai. Subsidiaries operate in more than thirty countries.
Do I need to speak German to work at Miltenyi?
It depends on the site. For Bergisch Gladbach HQ and Teterow manufacturing, working German (CEFR B2 or higher) is expected for most roles, even when the immediate team operates in English. For Auburn, Cambridge, Rome NY, Singapore, Tokyo, Seoul, and other international sites, English is sufficient for most positions, with regional languages (Mandarin, Japanese, Korean) preferred for local commercial and customer-facing roles.
What ATS does Miltenyi use and how should I format my application?
Miltenyi runs a custom careers portal at jobs.miltenyibiotec.com rather than a standard third-party ATS. Submit a single PDF combining cover letter, CV, transcripts, and references. For German roles, use the European CV format with photo. For US roles, an achievements-focused single-column CV works well. Keep formatting plain so the conservative parser captures all fields.
How long does the Miltenyi hiring process take?
Plan for four to ten weeks from application to offer. Recruiter screens come within one to three weeks for active requisitions. Interview loops run two to four rounds, plus a research seminar for PhD scientist roles. German hires also pass through Betriebsrat consultation, which adds time. Family-owned patience and genuine deliberation mean fast tracks are rare.
What is CliniMACS Prodigy and why does it matter for my career?
CliniMACS Prodigy is Miltenyi's closed-system, automated cell processing instrument. It is the de facto standard for academic CAR-T and other cell therapy manufacturing globally, competing with Lonza Cocoon, Cytiva Sefia, and emerging platforms. Joining a team that builds, sells, services, or develops therapies on Prodigy puts you at the center of one of the most strategically important platforms in cell therapy, which translates into long-term career durability.
Is Miltenyi affected by the post-COVID bioprocessing destocking?
Partially. The broader research reagents and bioprocessing market is still normalizing after the post-COVID inventory correction that hit peers like Sartorius and Cytiva. Cell therapy and CliniMACS Prodigy demand has been more resilient because of CAR-T expansion. Net effect: business is steady but not boom-era; expect deliberate hiring rather than aggressive expansion across the board.
How does compensation compare to BD, Danaher, or 10x Genomics?
Miltenyi pays competitively within the bio-tools and cell therapy sector but does not match Bay Area technology compensation. German HQ roles are tariff-banded with strong benefits, six weeks vacation, and pension contributions. US roles offer competitive base plus a meaningful annual bonus. There is no public stock equity because the company is private; long-term incentive structures vary by level and are not equivalent to public-market RSUs at BD, Danaher, Bio-Rad, Cytek, or 10x Genomics.
What is Miltenyi Biomedicine and is it separate from the tools business?
Miltenyi Biomedicine is the clinical-stage therapeutics arm developing cell therapy product candidates, including anti-CD19 CAR-T and NK cell therapy programs. It operates inside the broader Miltenyi organization today, but has been the subject of recurring spin-out speculation as the pipeline matures. Joining Biomedicine is closer to a clinical-stage biotech experience; joining the tools side is closer to a scientific instruments and reagents experience.
Are there labor unions or works councils at Miltenyi?
Yes, in Germany. IG BCE (the German chemical and energy workers' union) is the relevant industry union, and Miltenyi has an active Betriebsrat (works council) at HQ and Teterow that participates in hiring, schedules, and workplace policy decisions. This is normal for German industrial employers and provides meaningful worker protections rather than adversarial dynamics. US, UK, and Asia-Pacific sites are not unionized.
What background checks should I expect?
For most roles, employment verification, education verification, and reference checks are standard. For clinical, manufacturing, or quality roles touching GMP or patient material, occupational health screening (vaccinations, basic fitness for cleanroom work) is required before start. For senior or finance roles, more thorough background checks may apply. German roles also require a polizeiliches Fuehrungszeugnis (criminal background certificate) for some positions.
Does Miltenyi sponsor work visas?
Yes, selectively. For specialized scientific, engineering, and clinical roles where the local talent market is thin, Miltenyi sponsors EU Blue Card and equivalent permits in Germany, H-1B and TN in the US, and country-specific permits in Asia-Pacific. Sponsorship is more common for senior PhD scientists, regulatory specialists, and bioprocess engineers than for early-career or generalist roles. Check the specific posting and confirm with the recruiter early in the process.

Check Your Resume Before Applying → View open positions at Miltenyi Biotec

Related Resources

Similar Companies


Sources

  1. Miltenyi Biotec Careers Portal
  2. Miltenyi Biotec Corporate Website
  3. About Miltenyi Biotec - Company Overview
  4. Miltenyi Biotec - Wikipedia
  5. CliniMACS Prodigy Cell Processing Instrument
  6. Miltenyi Biomedicine - Cell Therapy Pipeline
  7. MACS Technology - Magnetic Activated Cell Sorting
  8. Miltenyi Biotec on LinkedIn
  9. IG BCE - Industriegewerkschaft Bergbau, Chemie, Energie
  10. Bergisch Gladbach Stadt - Wirtschaftsstandort
  11. Cytek Biosciences - Spectral Flow Cytometry Competitor
  12. 10x Genomics - Single-Cell Genomics Competitor
  13. BD Biosciences - Flow Cytometry Competitor
  14. Lonza Cocoon - Cell Therapy Manufacturing Platform
  15. Cytiva Sefia and Xuri - Cell Therapy Bioprocessing